Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate

Streptococcus pyogenes (group A streptococcus, GAS) causes a wide range of clinical manifestations ranging from mild self-limiting pyoderma to invasive diseases such as sepsis. Also of concern are the post-infectious immune-mediated diseases including rheumatic heart disease. The development of a va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Vaccin Immunother
Hauptverfasser: Batzloff, Michael R., Fane, Anne, Gorton, Davina, Pandey, Manisha, Rivera-Hernandez, Tania, Calcutt, Ainslie, Yeung, Grace, Hartas, Jon, Johnson, Linda, Rush, Catherine M., McCarthy, James, Ketheesan, Natkunam, Good, Michael F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2016
Schlagworte:
Short Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215552/
https://ncbi.nlm.nih.gov/pubmed/27541593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1222999
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge